Literature DB >> 34109597

Infectious agents including COVID-19 and the involvement of blood coagulation and fibrinolysis. A narrative review.

F Marongiu1, E Grandone, A Scano, G Orrù, S Marongiu, C Gerosa, D Fanni, G Faa, D Barcellona.   

Abstract

OBJECTIVE: Platelets, blood coagulation along with fibrinolysis are greatly involved in the pathophysiology of infectious diseases induced by bacteria, parasites and virus. This phenomenon is not surprising since both the innate immunity and the hemostatic systems are two ancestral mechanisms which closely cooperate favoring host's defense against foreign invaders. However, the excessive response of these systems may be dangerous for the host itself.
MATERIALS AND METHODS: We searched and retrieved the articles, using the following electronic database: MedLine and Embase. We limited our search to articles published in English, but no restrictions in terms of article type, publication year, and geography were adopted.
RESULTS: The hemostatic phenotype of the infectious diseases is variable depending on the points of attack of the different involved pathogens. Infectious diseases which show a prothrombotic phenotype are bacterial sepsis, SARS-CoV-2 and malaria. However, among the bacterial sepsis, Yersinia Pestis is characterized by a profibrinolytic behavior. On the contrary, the hemorrhagic fevers, due to Dengue and Ebola virus, mainly exploit the activation of fibrinolysis secondary to a huge endothelial damage which can release a large amount of t-PA in the early phase of the diseases.
CONCLUSIONS: Blood coagulation and fibrinolysis are greatly activated based on the strategy of the different infectious agents which exploit the excess of response of both systems to achieve the greatest possible virulence.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34109597     DOI: 10.26355/eurrev_202105_25956

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.

Authors:  Elvira Grandone; Antonella Vimercati; Felice Sorrentino; Donatella Colaizzo; Angelo Ostuni; Oronzo Ceci; Manuela Capozza; Giovanni Tiscia; Antonio De Laurenzo; Mario Mastroianno; Filomena Cappucci; Lucia Fischetti; Maurizio Margaglione; Ettore Cicinelli; Luigi Nappi
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-21       Impact factor: 3.007

2.  Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.

Authors:  M Carmen Martin; Ana Jimenez; Nuria Ortega; Alba Parrado; Isabel Page; M Isabel Gonzalez; Lydia Blanco-Peris
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

3.  Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.

Authors:  Sarah Kelliher; Luisa Weiss; Sarah Cullivan; Ellen O'Rourke; Claire A Murphy; Shane Toolan; Áine Lennon; Paulina B Szklanna; Shane P Comer; Hayley Macleod; Ana Le Chevillier; Sean Gaine; Kate M A O'Reilly; Brian McCullagh; John Stack; Patricia B Maguire; Fionnuala Ní Áinle; Barry Kevane
Journal:  J Thromb Haemost       Date:  2022-02-13       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.